APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pet Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025192 pages

Choose your research edition.

Industry ResearchPet Vaccine Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Vaccine Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Pet Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Vaccine Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Vaccine Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Pet Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pet Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pet Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pet Vaccine include CAHIC, Zoetis, Ringpu, Merck Animal Health, Keqian Biology, Jinyu Group, Virbac, Vetoquinol and Parnell, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pet Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Pet Vaccine Segment by Company

CAHIC

Zoetis

Ringpu

Merck Animal Health

Keqian Biology

Jinyu Group

Virbac

Vetoquinol

Parnell

Ouro Fino Saude

Meiji

Kyoritsu Seiyaku

Elanco Animal Health

Dechra Veterinary Products

Ceva

Boehringer Ingelheim

Animalcare Group

Pet Vaccine Segment by Type

Nasal Administration

Injection

Other

Pet Vaccine Segment by Application

Cat

Dog

Other

Pet Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pet Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pet Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pet Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pet Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pet Vaccine Industry Trends Table 2. Pet Vaccine Industry Drivers Table 3. Pet Vaccine Industry Opportunities and Challenges Table 4. Pet Vaccine Industry Restraints Table 5. Global Pet Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pet Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pet Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Pet Vaccine Sales Market Share by Manufacturers Table 9. Global Pet Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Pet Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pet Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pet Vaccine Manufacturers, Product Type & Application Table 13. Global Pet Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pet Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Nasal Administration Table 17. Major Manufacturers of Injection Table 18. Major Manufacturers of Other Table 19. Global Pet Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Pet Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Global Pet Vaccine Sales by Type (2027-2032) & (K Units) Table 22. Global Pet Vaccine Sales Market Share by Type (2021-2026) Table 23. Global Pet Vaccine Sales Market Share by Type (2027-2032) Table 24. Global Pet Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Pet Vaccine Revenue by Type (2021-2026) & (K Units) Table 26. Global Pet Vaccine Revenue by Type (2027-2032) & (K Units) Table 27. Global Pet Vaccine Revenue Market Share by Type (2021-2026) Table 28. Global Pet Vaccine Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Cat Table 30. Major Manufacturers of Dog Table 31. Major Manufacturers of Other Table 32. Global Pet Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Pet Vaccine Sales by Application (2021-2026) & (K Units) Table 34. Global Pet Vaccine Sales by Application (2027-2032) & (K Units) Table 35. Global Pet Vaccine Sales Market Share by Application (2021-2026) Table 36. Global Pet Vaccine Sales Market Share by Application (2027-2032) Table 37. Global Pet Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Pet Vaccine Revenue by Application (2021-2026) & (K Units) Table 39. Global Pet Vaccine Revenue by Application (2027-2032) & (K Units) Table 40. Global Pet Vaccine Revenue Market Share by Application (2021-2026) Table 41. Global Pet Vaccine Revenue Market Share by Application (2027-2032) Table 42. Global Pet Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Pet Vaccine Sales by Region (2021-2026) & (K Units) Table 44. Global Pet Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Pet Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Pet Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Pet Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Pet Vaccine Sales by Country (2021-2026) & (K Units) Table 49. North America Pet Vaccine Sales by Country (2027-2032) & (K Units) Table 50. Europe Pet Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Pet Vaccine Sales by Country (2021-2026) & (K Units) Table 52. Europe Pet Vaccine Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Pet Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Pet Vaccine Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Pet Vaccine Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Pet Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Pet Vaccine Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Pet Vaccine Sales by Country (2027-2032) & (K Units) Table 59. Global Pet Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Pet Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Pet Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Pet Vaccine Revenue Market Share by Region (2021-2026) Table 63. Global Pet Vaccine Revenue Market Share by Region (2027-2032) Table 64. CAHIC Company Information Table 65. CAHIC Business Overview Table 66. CAHIC Pet Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. CAHIC Pet Vaccine Product Portfolio Table 68. CAHIC Recent Development Table 69. Zoetis Company Information Table 70. Zoetis Business Overview Table 71. Zoetis Pet Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Zoetis Pet Vaccine Product Portfolio Table 73. Zoetis Recent Development Table 74. Ringpu Company Information Table 75. Ringpu Business Overview Table 76. Ringpu Pet Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Ringpu Pet Vaccine Product Portfolio Table 78. Ringpu Recent Development Table 79. Merck Animal Health Company Information Table 80. Merck Animal Health Business Overview Table 81. Merck Animal Health Pet Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Merck Animal Health Pet Vaccine Product Portfolio Table 83. Merck Animal Health Recent Development Table 84. Keqian Biology Company Information Table 85. Keqian Biology Business Overview Table 86. Keqian Biology Pet Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Keqian Biology Pet Vaccine Product Portfolio Table 88. Keqian Biology Recent Development Table 89. Jinyu Group Company Information Table 90. Jinyu Group Business Overview Table 91. Jinyu Group Pet Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Jinyu Group Pet Vaccine Product Portfolio Table 93. Jinyu Group Recent Development Table 94. Virbac Company Information Table 95. Virbac Business Overview Table 96. Virbac Pet Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Virbac Pet Vaccine Product Portfolio Table 98. Virbac Recent Development Table 99. Vetoquinol Company Information Table 100. Vetoquinol Business Overview Table 101. Vetoquinol Pet Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Vetoquinol Pet Vaccine Product Portfolio Table 103. Vetoquinol Recent Development Table 104. Parnell Company Information Table 105. Parnell Business Overview Table 106. Parnell Pet Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Parnell Pet Vaccine Product Portfolio Table 108. Parnell Recent Development Table 109. Ouro Fino Saude Company Information Table 110. Ouro Fino Saude Business Overview Table 111. Ouro Fino Saude Pet Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Ouro Fino Saude Pet Vaccine Product Portfolio Table 113. Ouro Fino Saude Recent Development Table 114. Meiji Company Information Table 115. Meiji Business Overview Table 116. Meiji Pet Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Meiji Pet Vaccine Product Portfolio Table 118. Meiji Recent Development Table 119. Kyoritsu Seiyaku Company Information Table 120. Kyoritsu Seiyaku Business Overview Table 121. Kyoritsu Seiyaku Pet Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Kyoritsu Seiyaku Pet Vaccine Product Portfolio Table 123. Kyoritsu Seiyaku Recent Development Table 124. Elanco Animal Health Company Information Table 125. Elanco Animal Health Business Overview Table 126. Elanco Animal Health Pet Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Elanco Animal Health Pet Vaccine Product Portfolio Table 128. Elanco Animal Health Recent Development Table 129. Dechra Veterinary Products Company Information Table 130. Dechra Veterinary Products Business Overview Table 131. Dechra Veterinary Products Pet Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Dechra Veterinary Products Pet Vaccine Product Portfolio Table 133. Dechra Veterinary Products Recent Development Table 134. Ceva Company Information Table 135. Ceva Business Overview Table 136. Ceva Pet Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Ceva Pet Vaccine Product Portfolio Table 138. Ceva Recent Development Table 139. Boehringer Ingelheim Company Information Table 140. Boehringer Ingelheim Business Overview Table 141. Boehringer Ingelheim Pet Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Boehringer Ingelheim Pet Vaccine Product Portfolio Table 143. Boehringer Ingelheim Recent Development Table 144. Animalcare Group Company Information Table 145. Animalcare Group Business Overview Table 146. Animalcare Group Pet Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Animalcare Group Pet Vaccine Product Portfolio Table 148. Animalcare Group Recent Development Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Pet Vaccine Distributors List Table 152. Pet Vaccine Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Pet Vaccine Product Image Figure 2. Global Pet Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Pet Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Pet Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pet Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Nasal Administration Image Figure 9. Injection Image Figure 10. Other Image Figure 11. Global Pet Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Pet Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Pet Vaccine Sales Market Share by Type (2021-2032) Figure 14. Global Pet Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Pet Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Pet Vaccine Revenue Market Share by Type (2021-2032) Figure 17. Cat Image Figure 18. Dog Image Figure 19. Other Image Figure 20. Global Pet Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Pet Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pet Vaccine Sales Market Share by Application (2021-2032) Figure 23. Global Pet Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Pet Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pet Vaccine Revenue Market Share by Application (2021-2032) Figure 26. North America Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Pet Vaccine Sales Market Share by Country (2021-2032) Figure 28. U.S. Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Pet Vaccine Sales Market Share by Country (2021-2032) Figure 33. Germany Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Pet Vaccine Sales Market Share by Country (2021-2032) Figure 40. China Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Pet Vaccine Sales Market Share by Country (2021-2032) Figure 48. Brazil Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Pet Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Pet Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Pet Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Pet Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. North America Pet Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Pet Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Europe Pet Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Pet Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Pet Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Pet Vaccine Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Pet Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Pet Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pet Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal Administration
  • Injection
  • Other
Applications
  • Cat
  • Dog
  • Other
Companies covered
  • CAHIC
  • Zoetis
  • Ringpu
  • Merck Animal Health
  • Keqian Biology
  • Jinyu Group
  • Virbac
  • Vetoquinol
  • Parnell
  • Ouro Fino Saude
  • Meiji
  • Kyoritsu Seiyaku
  • Elanco Animal Health
  • Dechra Veterinary Products
  • Ceva
  • Boehringer Ingelheim
  • Animalcare Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pet Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pet Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pet Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pet Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pet Vaccine Market Dynamics
  1. 2.1 Pet Vaccine Industry Trends
  2. 2.2 Pet Vaccine Industry Drivers
  3. 2.3 Pet Vaccine Industry Opportunities and Challenges
  4. 2.4 Pet Vaccine Industry Restraints
3 Pet Vaccine Market by Manufacturers
  1. 3.1 Global Pet Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pet Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pet Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pet Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pet Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pet Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Pet Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pet Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pet Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pet Vaccine Tier 1, Tier 2, and Tier 3
4 Pet Vaccine Market by Type
  1. 4.1 Pet Vaccine Type Introduction
  2. 4.1.1 Nasal Administration
  3. 4.1.2 Injection
  4. 4.1.3 Other
  5. 4.2 Global Pet Vaccine Sales by Type
  6. 4.2.1 Global Pet Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pet Vaccine Sales by Type (2021-2032)
  8. 4.2.3 Global Pet Vaccine Sales Market Share by Type (2021-2032)
  9. 4.3 Global Pet Vaccine Revenue by Type
  10. 4.3.1 Global Pet Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Pet Vaccine Revenue by Type (2021-2032)
  12. 4.3.3 Global Pet Vaccine Revenue Market Share by Type (2021-2032)
5 Pet Vaccine Market by Application
  1. 5.1 Pet Vaccine Application Introduction
  2. 5.1.1 Cat
  3. 5.1.2 Dog
  4. 5.1.3 Other
  5. 5.2 Global Pet Vaccine Sales by Application
  6. 5.2.1 Global Pet Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pet Vaccine Sales by Application (2021-2032)
  8. 5.2.3 Global Pet Vaccine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pet Vaccine Revenue by Application
  10. 5.3.1 Global Pet Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pet Vaccine Revenue by Application (2021-2032)
  12. 5.3.3 Global Pet Vaccine Revenue Market Share by Application (2021-2032)
6 Global Pet Vaccine Sales by Region
  1. 6.1 Global Pet Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Pet Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Pet Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pet Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pet Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pet Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pet Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pet Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pet Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pet Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pet Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pet Vaccine Revenue by Region
  1. 7.1 Global Pet Vaccine Revenue by Region
  2. 7.1.1 Global Pet Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pet Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Pet Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Pet Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pet Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Pet Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pet Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Pet Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pet Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pet Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pet Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pet Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CAHIC
  2. 8.1.1 CAHIC Company Information
  3. 8.1.2 CAHIC Business Overview
  4. 8.1.3 CAHIC Pet Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CAHIC Pet Vaccine Product Portfolio
  6. 8.1.5 CAHIC Recent Developments
  7. 8.2 Zoetis
  8. 8.2.1 Zoetis Company Information
  9. 8.2.2 Zoetis Business Overview
  10. 8.2.3 Zoetis Pet Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zoetis Pet Vaccine Product Portfolio
  12. 8.2.5 Zoetis Recent Developments
  13. 8.3 Ringpu
  14. 8.3.1 Ringpu Company Information
  15. 8.3.2 Ringpu Business Overview
  16. 8.3.3 Ringpu Pet Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ringpu Pet Vaccine Product Portfolio
  18. 8.3.5 Ringpu Recent Developments
  19. 8.4 Merck Animal Health
  20. 8.4.1 Merck Animal Health Company Information
  21. 8.4.2 Merck Animal Health Business Overview
  22. 8.4.3 Merck Animal Health Pet Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck Animal Health Pet Vaccine Product Portfolio
  24. 8.4.5 Merck Animal Health Recent Developments
  25. 8.5 Keqian Biology
  26. 8.5.1 Keqian Biology Company Information
  27. 8.5.2 Keqian Biology Business Overview
  28. 8.5.3 Keqian Biology Pet Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Keqian Biology Pet Vaccine Product Portfolio
  30. 8.5.5 Keqian Biology Recent Developments
  31. 8.6 Jinyu Group
  32. 8.6.1 Jinyu Group Company Information
  33. 8.6.2 Jinyu Group Business Overview
  34. 8.6.3 Jinyu Group Pet Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jinyu Group Pet Vaccine Product Portfolio
  36. 8.6.5 Jinyu Group Recent Developments
  37. 8.7 Virbac
  38. 8.7.1 Virbac Company Information
  39. 8.7.2 Virbac Business Overview
  40. 8.7.3 Virbac Pet Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Virbac Pet Vaccine Product Portfolio
  42. 8.7.5 Virbac Recent Developments
  43. 8.8 Vetoquinol
  44. 8.8.1 Vetoquinol Company Information
  45. 8.8.2 Vetoquinol Business Overview
  46. 8.8.3 Vetoquinol Pet Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Vetoquinol Pet Vaccine Product Portfolio
  48. 8.8.5 Vetoquinol Recent Developments
  49. 8.9 Parnell
  50. 8.9.1 Parnell Company Information
  51. 8.9.2 Parnell Business Overview
  52. 8.9.3 Parnell Pet Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Parnell Pet Vaccine Product Portfolio
  54. 8.9.5 Parnell Recent Developments
  55. 8.10 Ouro Fino Saude
  56. 8.10.1 Ouro Fino Saude Company Information
  57. 8.10.2 Ouro Fino Saude Business Overview
  58. 8.10.3 Ouro Fino Saude Pet Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ouro Fino Saude Pet Vaccine Product Portfolio
  60. 8.10.5 Ouro Fino Saude Recent Developments
  61. 8.11 Meiji
  62. 8.11.1 Meiji Company Information
  63. 8.11.2 Meiji Business Overview
  64. 8.11.3 Meiji Pet Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Meiji Pet Vaccine Product Portfolio
  66. 8.11.5 Meiji Recent Developments
  67. 8.12 Kyoritsu Seiyaku
  68. 8.12.1 Kyoritsu Seiyaku Company Information
  69. 8.12.2 Kyoritsu Seiyaku Business Overview
  70. 8.12.3 Kyoritsu Seiyaku Pet Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Kyoritsu Seiyaku Pet Vaccine Product Portfolio
  72. 8.12.5 Kyoritsu Seiyaku Recent Developments
  73. 8.13 Elanco Animal Health
  74. 8.13.1 Elanco Animal Health Company Information
  75. 8.13.2 Elanco Animal Health Business Overview
  76. 8.13.3 Elanco Animal Health Pet Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Elanco Animal Health Pet Vaccine Product Portfolio
  78. 8.13.5 Elanco Animal Health Recent Developments
  79. 8.14 Dechra Veterinary Products
  80. 8.14.1 Dechra Veterinary Products Company Information
  81. 8.14.2 Dechra Veterinary Products Business Overview
  82. 8.14.3 Dechra Veterinary Products Pet Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Dechra Veterinary Products Pet Vaccine Product Portfolio
  84. 8.14.5 Dechra Veterinary Products Recent Developments
  85. 8.15 Ceva
  86. 8.15.1 Ceva Company Information
  87. 8.15.2 Ceva Business Overview
  88. 8.15.3 Ceva Pet Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Ceva Pet Vaccine Product Portfolio
  90. 8.15.5 Ceva Recent Developments
  91. 8.16 Boehringer Ingelheim
  92. 8.16.1 Boehringer Ingelheim Company Information
  93. 8.16.2 Boehringer Ingelheim Business Overview
  94. 8.16.3 Boehringer Ingelheim Pet Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Boehringer Ingelheim Pet Vaccine Product Portfolio
  96. 8.16.5 Boehringer Ingelheim Recent Developments
  97. 8.17 Animalcare Group
  98. 8.17.1 Animalcare Group Company Information
  99. 8.17.2 Animalcare Group Business Overview
  100. 8.17.3 Animalcare Group Pet Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Animalcare Group Pet Vaccine Product Portfolio
  102. 8.17.5 Animalcare Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pet Vaccine Value Chain Analysis
  2. 9.1.1 Pet Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pet Vaccine Production Mode & Process
  6. 9.2 Pet Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pet Vaccine Distributors
  9. 9.2.3 Pet Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst